Latest Articles
- Influenza 2010–2011: Lessons from the 2009 pandemic
The 2009 pandemic of influenza A (H1N1) was less severe than some others, thanks in part to advances in diagnosis, treatment, and public health.
- Intracerebral hemorrhage: Pick your poison
Whether to resume anticoagulant therapy after an intracerebral hemorrhage requires careful consideration of many factors, including patient preferences and tolerance of different levels of risk.
- When ‘blue babies’ grow up: What you need to know about tetralogy of Fallot
Children born with tetralogy of Fallot and other congenital heart defects are living longer—long enough, eventually, to present to your clinic.
- What’s new in treating older adults?
Recent studies and trials regarding bone loss, dialysis outcomes, dementia, and other topics.
- Preventing clots: Don’t let the complex overshadow the simple
Although we often approach anticoagulation therapy with a confidence born of familiarity, it is not for the faint of heart.
Approach to a low TSH level: Patience is a virtueConfronted with a low TSH level, physicians should not jump to the conclusion that it is due to a hyperthyroid state.
- Noninvasive positive pressure ventilation for stable outpatients: CPAP and beyond
We discuss the different types of noninvasive positive pressure ventilation, the specific conditions in which they can be used, and the evidence supporting their efficacy in outpatients.
- Should healthy people take a multivitamin?
No. There is no scientific basis for recommending vitamin-mineral supplements to the healthy population.